Data Dictionary: Belgian Cancer Registry: Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
|+ Patient Information and Treatment Data | |+ Patient Information and Treatment Data | ||
|- | |- | ||
! | ! Variable !! Description | ||
|- | |- | ||
| Unique patient identification including demographic parameters || (i.e., date of birth, gender, zip code) and unique identification of the care program and hospital | | Unique patient identification including demographic parameters || (i.e., date of birth, gender, zip code) and unique identification of the care program and hospital | ||
Revision as of 14:08, 30 April 2024
Go back to Belgium page
Source:
| Variable | Description |
|---|---|
| Unique patient identification including demographic parameters | (i.e., date of birth, gender, zip code) and unique identification of the care program and hospital |
| Diagnosis according to international classification | including date of incidence |
| Tumor stage (cTNM) | |
| Conclusion of the pathological report | (including pTNM) |
| Treatment with reference to guidelines or justification of deviation | |
| Follow-up plan | |
| Side effects | |
| Disease-free survival and survival | (i.e., treatment outcome) |
| Date of death |
Source: Click here to learn more.
| Aspects of Participation and Screening Test Usage |
| Aspects of participation |
| Use of the screening test in the target group |
| Results obtained and their use (including cancer detection rate, sensitivity, and specificity) |
| Cyto-histopathology register |
| Results of further follow-up |